Beruflich Dokumente
Kultur Dokumente
---- in Rs.
Cr.
---------------
Balance Sheet ----
Mar '06 Mar '07 Mar '08 Mar '09 Mar '10
Sources Of Funds
Total Share Capital 59.97 155.46 155.46 155.46 160.58
Equity Share Capital 59.97 155.46 155.46 155.46 160.58
Share Application Money 0.00 0.00 0.00 0.00 0.00
Preference Share Capital 0.00 0.00 0.00 0.00 0.00
Reserves 1,913.98 3,071.84 3,591.39 4,186.32 5,744.54
Revaluation Reserves 9.32 8.97 8.97 8.97 8.97
Networth 1,983.27 3,236.27 3,755.82 4,350.75 5,914.09
Secured Loans 51.27 7.25 16.98 2.79 0.41
Unsecured Loans 417.64 116.31 563.55 937.45 4.66
Total Debt 468.91 123.56 580.53 940.24 5.07
Total Liabilities 2,452.18 3,359.83 4,336.35 5,290.99 5,919.16
Mar '06 Mar '07 Mar '08 Mar '09 Mar '10
Application Of Funds
Gross Block 1,366.67 1,799.71 2,201.79 2,693.29 2,895.44
Less: Accum. Depreciation 310.06 411.64 540.43 700.80 884.27
Net Block 1,056.61 1,388.07 1,661.36 1,992.49 2,011.17
Capital Work in Progress 87.01 73.19 233.12 366.32 684.24
Investments 22.43 117.80 94.75 81.32 265.10
Inventories 957.00 978.60 1,120.49 1,398.32 1,512.58
Sundry Debtors 875.96 1,028.78 1,393.91 1,837.15 1,552.71
Cash and Bank Balance 44.45 56.33 79.12 52.84 60.32
Total Current Assets 1,877.41 2,063.71 2,593.52 3,288.31 3,125.61
Loans and Advances 414.84 695.81 1,150.30 1,131.10 2,357.29
Fixed Deposits 0.03 75.16 0.16 0.16 0.52
Total CA, Loans & Advances 2,292.28 2,834.68 3,743.98 4,419.57 5,483.42
Deffered Credit 0.00 0.00 0.00 0.00 0.00
Current Liabilities 733.84 643.78 980.05 1,177.00 1,177.11
Provisions 272.31 410.13 416.81 391.71 1,347.66
Total CL & Provisions 1,006.15 1,053.91 1,396.86 1,568.71 2,524.77
Net Current Assets 1,286.13 1,780.77 2,347.12 2,850.86 2,958.65
Miscellaneous Expenses 0.00 0.00 0.00 0.00 0.00
Total Assets 2,452.18 3,359.83 4,336.35 5,290.99 5,919.16
Income
Sales Turnover 3,103.62 3,656.92 4,293.95 5,295.33 5,657.85
Excise Duty 122.27 94.93 90.66 61.04 52.16
Net Sales 2,981.35 3,561.99 4,203.29 5,234.29 5,605.69
Other Income 112.20 100.68 134.92 -139.51 125.71
Stock Adjustments 94.35 -30.73 41.37 113.55 184.09
Total Income 3,187.90 3,631.94 4,379.58 5,208.33 5,915.49
Expenditure
Raw Materials 1,564.11 1,754.89 2,162.48 2,513.11 2,687.54
Power & Fuel Cost 63.08 86.71 96.90 91.71 92.15
Employee Cost 150.76 184.59 255.45 271.33 318.87
Other Manufacturing Expenses 170.63 186.47 233.90 262.65 259.67
Selling and Admin Expenses 354.33 418.34 547.10 887.28 867.98
Miscellaneous Expenses 78.90 78.43 96.66 76.92 182.64
Preoperative Exp Capitalised 0.00 0.00 0.00 0.00 0.00
Total Expenses 2,381.81 2,709.43 3,392.49 4,103.00 4,408.85
Mar '06 Mar '07 Mar '08 Mar '09 Mar '10
Mar '06 Mar '07 Mar '08 Mar '09 Mar '10
Mar '06 Mar '07 Mar '08 Mar '09 Mar '10
42.392
6.478
53.922
0
24.606
21.156
74.63
78.262
0.5
---------------
---- in Rs.
Cr.
---------------
Balance Sheet of Ranbaxy Laboratories ----
Dec '05 Dec '06 Dec '07 Dec '08 Dec '09
Sources Of Funds
Total Share Capital 186.22 186.34 186.54 210.19 210.21
Equity Share Capital 186.22 186.34 186.54 210.19 210.21
Share Application Money 0.28 0.88 1.18 175.66 175.85
Preference Share Capital 0.00 0.00 0.00 0.00 0.00
Reserves 2,190.80 2,162.79 2,350.68 3,330.92 3,748.54
Revaluation Reserves 0.00 0.00 0.00 0.00 0.00
Networth 2,377.30 2,350.01 2,538.40 3,716.77 4,134.60
Secured Loans 353.49 224.29 365.07 162.07 175.83
Unsecured Loans 676.31 2,954.31 3,137.96 3,563.30 3,172.55
Total Debt 1,029.80 3,178.60 3,503.03 3,725.37 3,348.38
Total Liabilities 3,407.10 5,528.61 6,041.43 7,442.14 7,482.98
Dec '05 Dec '06 Dec '07 Dec '08 Dec '09
Application Of Funds
Gross Block 1,799.32 2,133.57 2,261.48 2,386.75 2,620.92
Less: Accum. Depreciation 599.35 699.54 791.96 930.07 1,027.52
Net Block 1,199.97 1,434.03 1,469.52 1,456.68 1,593.40
Capital Work in Progress 432.84 301.88 327.42 428.77 414.92
Investments 762.78 2,679.95 3,237.55 3,618.03 3,833.69
Inventories 890.93 954.91 976.07 1,198.52 1,230.48
Sundry Debtors 806.62 1,013.75 882.91 1,024.54 1,534.65
Cash and Bank Balance 30.48 27.06 69.38 49.86 25.56
Total Current Assets 1,728.03 1,995.72 1,928.36 2,272.92 2,790.69
Loans and Advances 594.94 581.18 882.99 2,351.98 1,967.65
Fixed Deposits 86.11 44.09 111.07 1,885.08 728.56
Total CA, Loans & Advances 2,409.08 2,620.99 2,922.42 6,509.98 5,486.90
Deffered Credit 0.00 0.00 0.00 0.00 0.00
Current Liabilities 983.57 985.57 1,177.35 3,840.11 3,082.89
Provisions 413.99 522.67 738.14 731.20 763.03
Total CL & Provisions 1,397.56 1,508.24 1,915.49 4,571.31 3,845.92
Net Current Assets 1,011.52 1,112.75 1,006.93 1,938.67 1,640.98
Miscellaneous Expenses 0.00 0.00 0.00 0.00 0.00
Total Assets 3,407.11 5,528.61 6,041.42 7,442.15 7,482.99
Income
Sales Turnover 3,727.05 4,218.98 4,344.39 4,676.21 4,797.49
Excise Duty 86.56 53.86 51.37 24.17 15.90
Net Sales 3,640.49 4,165.12 4,293.02 4,652.04 4,781.59
Other Income 122.25 -28.65 551.13 -1,587.64 485.66
Stock Adjustments 30.96 44.70 40.66 115.59 33.96
Total Income 3,793.70 4,181.17 4,884.81 3,179.99 5,301.21
Expenditure
Raw Materials 1,567.55 1,708.23 1,861.17 2,049.30 1,916.58
Power & Fuel Cost 69.55 80.70 90.35 108.83 109.57
Employee Cost 298.38 328.45 420.04 472.65 582.50
Other Manufacturing Expenses 67.09 79.52 82.60 94.65 89.94
Selling and Admin Expenses 1,339.12 1,234.42 1,341.03 1,402.77 1,306.25
Miscellaneous Expenses 144.32 146.23 123.90 383.26 158.07
Preoperative Exp Capitalised 0.00 0.00 0.00 0.00 0.00
Total Expenses 3,486.01 3,577.55 3,919.09 4,511.46 4,162.91
Dec '05 Dec '06 Dec '07 Dec '08 Dec '09
Dec '05 Dec '06 Dec '07 Dec '08 Dec '09
Imported Composition of Raw Materials Consumed 54.67 55.17 51.63 51.56 65.79
Selling Distribution Cost Composition 14.73 12.98 14.01 12.84 7.74
Expenses as Composition of Total Sales 64.76 66.16 61.98 61.34 65.59
Cash Flow Indicator Ratios
Dividend Payout Ratio Net Profit 170.28 94.95 60.06 -- --
Dividend Payout Ratio Cash Profit 115.22 74.15 50.38 -- --
Earning Retention Ratio -259.14 16.89 -668.18 -- 100
Cash Earning Retention Ratio -78.86 33.28 -122.14 100 100
AdjustedCash Flow Times 5.1 5.87 20.97 4.83 15.13
Dec '05 Dec '06 Dec '07 Dec '08 Dec '09
55.764
12.46
63.966
0
65.058
47.95
-162.086
6.456
10.38
---------------
---- in Rs.
Cr.
---------------
Balance Sheet of GlaxoSmithKline Pharmaceuticals ----
Dec '05 Dec '06 Dec '07 Dec '08 Dec '09
Sources Of Funds
Total Share Capital 84.70 84.70 84.70 84.70 84.70
Equity Share Capital 84.70 84.70 84.70 84.70 84.70
Share Application Money 0.00 0.00 0.00 0.00 0.00
Preference Share Capital 0.00 0.00 0.00 0.00 0.00
Reserves 863.90 1,110.01 1,276.21 1,456.39 1,674.45
Revaluation Reserves 0.00 0.00 0.00 0.00 0.00
Networth 948.60 1,194.71 1,360.91 1,541.09 1,759.15
Secured Loans 0.00 0.00 0.00 0.00 0.00
Unsecured Loans 4.85 5.54 5.77 5.65 5.42
Total Debt 4.85 5.54 5.77 5.65 5.42
Total Liabilities 953.45 1,200.25 1,366.68 1,546.74 1,764.57
Dec '05 Dec '06 Dec '07 Dec '08 Dec '09
Application Of Funds
Gross Block 253.11 253.63 266.71 282.15 289.18
Less: Accum. Depreciation 171.54 167.83 179.24 191.75 196.37
Net Block 81.57 85.80 87.47 90.40 92.81
Capital Work in Progress 15.37 8.66 5.43 9.95 21.36
Investments 913.06 1,139.41 1,333.32 751.87 190.91
Inventories 218.13 240.95 205.96 228.38 253.02
Sundry Debtors 67.39 60.45 37.77 57.94 53.73
Cash and Bank Balance 47.53 28.68 45.91 43.79 74.75
Total Current Assets 333.05 330.08 289.64 330.11 381.50
Loans and Advances 169.93 206.40 188.87 236.86 187.35
Fixed Deposits 0.00 6.35 109.08 862.75 1,597.85
Total CA, Loans & Advances 502.98 542.83 587.59 1,429.72 2,166.70
Deffered Credit 0.00 0.00 0.00 0.00 0.00
Current Liabilities 268.97 258.29 254.59 280.71 324.25
Provisions 290.55 318.15 392.55 454.51 382.96
Total CL & Provisions 559.52 576.44 647.14 735.22 707.21
Net Current Assets -56.54 -33.61 -59.55 694.50 1,459.49
Miscellaneous Expenses 0.00 0.00 0.00 0.00 0.00
Total Assets 953.46 1,200.26 1,366.67 1,546.72 1,764.57
Income
Sales Turnover 1,579.58 1,681.07 1,721.12 1,762.64 1,924.27
Excise Duty 105.51 139.14 142.54 86.28 40.13
Net Sales 1,474.07 1,541.93 1,578.58 1,676.36 1,884.14
Other Income 262.55 254.01 241.51 216.03 91.39
Stock Adjustments -0.54 22.58 -16.80 2.33 32.41
Total Income 1,736.08 1,818.52 1,803.29 1,894.72 2,007.94
Expenditure
Raw Materials 637.26 651.18 616.40 653.26 728.65
Power & Fuel Cost 16.61 19.23 20.54 24.75 24.66
Employee Cost 156.06 153.87 151.45 173.05 209.71
Other Manufacturing Expenses 28.97 40.35 43.33 46.55 52.03
Selling and Admin Expenses 167.56 143.93 136.31 140.68 182.82
Miscellaneous Expenses 44.37 43.80 12.27 12.27 10.02
Preoperative Exp Capitalised 0.00 0.00 0.00 0.00 0.00
Total Expenses 1,050.83 1,052.36 980.30 1,050.56 1,207.89
Dec '05 Dec '06 Dec '07 Dec '08 Dec '09
Dec '05 Dec '06 Dec '07 Dec '08 Dec '09
Dec '05 Dec '06 Dec '07 Dec '08 Dec '09
Sources Of Funds
Total Share Capital 95.17 80.17 41.80 41.80 41.80
Equity Share Capital 41.80 41.80 41.80 41.80 41.80
Share Application Money 0.00 0.00 0.00 0.00 0.00
Preference Share Capital 53.37 38.37 0.00 0.00 0.00
Reserves 874.29 976.22 974.67 1,147.22 1,458.83
Revaluation Reserves 0.00 0.00 0.00 0.00 0.00
Networth 969.46 1,056.39 1,016.47 1,189.02 1,500.63
Secured Loans 162.05 179.33 151.17 448.01 406.53
Unsecured Loans 31.20 216.88 353.12 528.85 254.43
Total Debt 193.25 396.21 504.29 976.86 660.96
Total Liabilities 1,162.71 1,452.60 1,520.76 2,165.88 2,161.59
Mar '06 Mar '07 Mar '08 Mar '09 Mar '10
Application Of Funds
Gross Block 891.84 1,152.56 1,137.23 1,427.81 1,570.25
Less: Accum. Depreciation 216.60 282.41 329.00 409.09 496.36
Net Block 675.24 870.15 808.23 1,018.72 1,073.89
Capital Work in Progress 175.45 45.97 47.82 46.33 50.56
Investments 78.94 126.50 128.26 129.98 192.65
Inventories 214.75 226.48 252.49 288.00 285.47
Sundry Debtors 174.75 229.88 302.92 361.88 273.07
Cash and Bank Balance 10.92 22.05 13.95 17.47 15.64
Total Current Assets 400.42 478.41 569.36 667.35 574.18
Loans and Advances 211.44 292.62 450.59 865.93 915.93
Fixed Deposits 0.00 0.00 20.12 0.00 0.00
Total CA, Loans & Advances 611.86 771.03 1,040.07 1,533.28 1,490.11
Deffered Credit 0.00 0.00 0.00 0.00 0.00
Current Liabilities 294.12 336.23 384.67 445.20 491.80
Provisions 84.66 24.82 118.95 117.23 153.82
Total CL & Provisions 378.78 361.05 503.62 562.43 645.62
Net Current Assets 233.08 409.98 536.45 970.85 844.49
Miscellaneous Expenses 0.00 0.00 0.00 0.00 0.00
Total Assets 1,162.71 1,452.60 1,520.76 2,165.88 2,161.59
Income
Sales Turnover 1,521.59 1,708.70 2,001.26 2,386.95 2,711.74
Excise Duty 97.74 99.04 83.55 65.04 57.24
Net Sales 1,423.85 1,609.66 1,917.71 2,321.91 2,654.50
Other Income 48.21 57.62 74.83 71.57 133.30
Stock Adjustments -74.11 18.57 -4.13 12.35 21.44
Total Income 1,397.95 1,685.85 1,988.41 2,405.83 2,809.24
Expenditure
Raw Materials 549.36 683.03 802.20 969.48 1,139.24
Power & Fuel Cost 26.52 39.48 48.16 48.68 50.25
Employee Cost 154.41 188.62 239.51 255.16 303.74
Other Manufacturing Expenses 45.26 49.27 32.58 37.28 33.81
Selling and Admin Expenses 274.85 328.03 323.76 421.89 461.93
Miscellaneous Expenses 66.17 64.64 66.87 94.26 94.43
Preoperative Exp Capitalised 0.00 0.00 0.00 0.00 0.00
Total Expenses 1,116.57 1,353.07 1,513.08 1,826.75 2,083.40
Mar '06 Mar '07 Mar '08 Mar '09 Mar '10
---------------
---- in Rs.
Cr.
---------------
Key Financial Ratios ----
Mar '06 Mar '07 Mar '08 Mar '09 Mar '10
Face Value 2 2 2 2 2
Dividend Per Share 3 3.5 4.2 4.2 5.4
Operating Profit Per Share (Rs) 11.16 13.16 19.16 24.28 28.35
Net Operating Profit Per Share (Rs) 68.12 77.01 91.75 111.09 127
Free Reserves Per Share (Rs) 41.73 45.89 43.98 50.68 64.04
Bonus in Equity Capital 18.7 18.7 18.7 18.7 18.7
Profitability Ratios
Operating Profit Margin(%) 16.37 17.09 20.88 21.85 22.32
Profit Before Interest And Tax Margin(%) 11.97 12.24 16.58 17.06 17.87
Gross Profit Margin(%) 16.93 17.78 17.2 18.24 18.84
Cash Profit Margin(%) 15.56 15.48 18.71 18.1 19.55
Adjusted Cash Margin(%) 15.13 15.75 18.71 18.1 19.55
Net Profit Margin(%) 11.62 11.26 15.14 11.08 15.83
Adjusted Net Profit Margin(%) 11.19 11.54 15.14 11.08 15.83
Return On Capital Employed(%) 18.62 18.35 26.47 26.99 29.83
Return On Net Worth(%) 17.57 17.82 29.52 23.15 29.53
Adjusted Return on Net Worth(%) 17.59 18.72 29.58 30.74 30.33
Dividend Payout Ratio Net Profit 42.91 45.19 34.29 37.3 29.69
Dividend Payout Ratio Cash Profit 31.92 32.77 27.77 28.59 24.57
Earning Retention Ratio 55.39 55.91 65.78 71.91 71.09
Cash Earning Retention Ratio 67.16 67.82 72.28 77.15 75.96
AdjustedCash Flow Times 0.87 1.5 1.35 2.17 1.21
Mar '06 Mar '07 Mar '08 Mar '09 Mar '10
41.5
26.56
7.272
19.452
0
37.876
29.124
64.016
72.074
1.42
---------------
---- in Rs.
Cr.
---------------
Balance Sheet of Sun Pharmaceutical Industries ----
Mar '06 Mar '07 Mar '08 Mar '09 Mar '10
Sources Of Funds
Total Share Capital 94.27 98.07 103.56 103.56 103.56
Equity Share Capital 92.87 96.70 103.56 103.56 103.56
Share Application Money 0.00 0.00 0.00 0.00 0.00
Preference Share Capital 1.40 1.37 0.00 0.00 0.00
Reserves 1,370.67 2,351.42 4,104.06 5,047.86 5,614.42
Revaluation Reserves 0.00 0.00 0.00 0.00 0.00
Networth 1,464.94 2,449.49 4,207.62 5,151.42 5,717.98
Secured Loans 18.23 20.39 22.88 23.60 29.49
Unsecured Loans 1,727.59 1,047.76 79.64 0.00 0.00
Total Debt 1,745.82 1,068.15 102.52 23.60 29.49
Total Liabilities 3,210.76 3,517.64 4,310.14 5,175.02 5,747.47
Mar '06 Mar '07 Mar '08 Mar '09 Mar '10
Application Of Funds
Gross Block 744.26 838.70 935.03 1,061.90 1,159.76
Less: Accum. Depreciation 208.07 249.41 304.99 362.64 419.24
Net Block 536.19 589.29 630.04 699.26 740.52
Capital Work in Progress 30.80 31.91 33.43 75.95 92.15
Investments 779.62 1,057.49 1,843.57 2,694.59 3,951.69
Inventories 263.41 333.38 389.63 486.74 570.14
Sundry Debtors 256.47 310.00 1,055.44 680.03 553.29
Cash and Bank Balance 11.26 35.69 23.29 20.17 26.11
Total Current Assets 531.14 679.07 1,468.36 1,186.94 1,149.54
Loans and Advances 509.25 345.82 394.13 311.42 383.34
Fixed Deposits 1,219.56 1,166.99 1,049.13 1,245.30 161.16
Total CA, Loans & Advances 2,259.95 2,191.88 2,911.62 2,743.66 1,694.04
Deffered Credit 0.00 0.00 0.00 0.00 0.00
Current Liabilities 273.30 345.23 845.73 696.34 388.45
Provisions 122.50 7.70 262.79 342.10 342.48
Total CL & Provisions 395.80 352.93 1,108.52 1,038.44 730.93
Net Current Assets 1,864.15 1,838.95 1,803.10 1,705.22 963.11
Miscellaneous Expenses 0.00 0.00 0.00 0.00 0.00
Total Assets 3,210.76 3,517.64 4,310.14 5,175.02 5,747.47
Income
Sales Turnover 1,353.01 1,722.13 2,427.35 2,833.65 1,891.16
Excise Duty 61.37 59.57 58.84 59.00 46.07
Net Sales 1,291.64 1,662.56 2,368.51 2,774.65 1,845.09
Other Income 525.55 750.26 914.83 1,276.22 765.98
Stock Adjustments 57.23 41.41 17.38 23.78 30.91
Total Income 1,874.42 2,454.23 3,300.72 4,074.65 2,641.98
Expenditure
Raw Materials 899.67 1,214.48 1,564.61 1,961.89 878.46
Power & Fuel Cost 25.55 31.14 37.36 50.44 47.38
Employee Cost 82.01 98.87 120.20 148.31 174.71
Other Manufacturing Expenses 23.11 25.08 35.21 43.93 52.90
Selling and Admin Expenses 287.47 370.20 415.35 494.98 439.11
Miscellaneous Expenses 15.97 18.85 14.62 18.06 31.92
Preoperative Exp Capitalised 0.00 0.00 0.00 0.00 0.00
Total Expenses 1,333.78 1,758.62 2,187.35 2,717.61 1,624.48
Mar '06 Mar '07 Mar '08 Mar '09 Mar '10
Mar '06 Mar '07 Mar '08 Mar '09 Mar '10
Imported Composition of Raw Materials Consumed 42.96 39.26 40.06 41.63 44.38
Selling Distribution Cost Composition 9.4 8.6 8.01 8.54 10.67
Expenses as Composition of Total Sales 31.34 28.98 37.79 29.84 46.11
Cash Flow Indicator Ratios
Dividend Payout Ratio Net Profit 25.29 23.57 25.11 26.33 36.95
Dividend Payout Ratio Cash Profit 23.24 21.96 23.79 25.16 34.3
Earning Retention Ratio 72.76 74.08 74.55 73.11 64.28
Cash Earning Retention Ratio 75.12 76.02 75.9 74.33 66.76
AdjustedCash Flow Times 3.72 1.73 0.1 0.02 0.03
Mar '06 Mar '07 Mar '08 Mar '09 Mar '10
41.658
9.044
34.812
0
27.45
25.69
71.756
73.626
1.12
Industry trend CIPLA Ranbaxy
Profitability Ratios
Operating Profit Margin(%) 18.2156 23.004 9.7
Profit Before Interest And Tax Margin(%) 14.868 19.772 6.718
Gross Profit Margin(%) 19.3908 21.57 7.878
Cash Profit Margin(%) 22.616 20.95 11.604
Adjusted Cash Margin(%) 20.4348 20.266 8.61
Net Profit Margin(%) 19.134 17.702 3.776
Adjusted Net Profit Margin(%) 16.9536 17.018 0.784
Return On Capital Employed(%) 23.6208 22.558 5.72
Return On Net Worth(%) 23.3816 21.28 6.878
Adjusted Return on Net Worth(%) 21.7804 20.844 8.772
Return on Assets Excluding Revaluations 88.4604 47.34 51.246
Return on Assets Including Revaluations 88.4808 47.442 51.246
Return on Long Term Funds(%) 24.4368 23.576 6.898
Liquidity And Solvency Ratios
Current Ratio 1.984 2.264 1.01
Quick Ratio 1.7244 1.694 0.946
Debt Equity Ratio 0.3936 0.13 1.012
Long Term Debt Equity Ratio 0.2948 0.084 0.676
Debt Coverage Ratios
Interest Cover 359.6476 66.036 6.638
Total Debt to Owners Fund 0.3936 0.13 1.012
Financial Charges Coverage Ratio 326.834 50.714 8.986
Financial Charges Coverage Ratio Post Tax 277.5624 44.97 9.046
Management Efficiency Ratios
Inventory Turnover Ratio 5.912 3.646 4.208
Debtors Turnover Ratio 9.842 3.566 4.462
Investments Turnover Ratio 5.9184 3.668 4.374
Fixed Assets Turnover Ratio 4.6228 2.314 2.5
Total Assets Turnover Ratio 1.0032 1.038 0.786
Asset Turnover Ratio 2.9396 1.99 2.11